+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alkermes plc - logo

Alkermes is a leader in innovative medicines that address the needs of people living with debilitating diseases. Alkermes develops products that are designed to make a meaningful difference in the way patients manage their disease. Alkermes produces innovative treatments for major clinical conditions specifically focused on central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis.

Addiction Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Addiction Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 87 Pages
  • Global
From
Schizophrenia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Schizophrenia Therapeutics - Global Strategic Business Report

  • Report
  • October 2026
  • 236 Pages
  • Global
From
Endometrial Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Endometrial Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 532 Pages
  • Global
From
Fallopian Tube Cancer Therapeutics Market - Global Strategic Business Report - Product Thumbnail Image

Fallopian Tube Cancer Therapeutics Market - Global Strategic Business Report

  • Report
  • October 2026
  • 139 Pages
  • Global
From
Schizophrenia Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Schizophrenia Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2022
  • 85 Pages
  • Global
From
Cervical Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Cervical Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 700 Pages
  • Global
From
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1560 Pages
  • Global
From
Bile Duct Cancer (Cholangiocarcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 507 Pages
  • Global
From
Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1588 Pages
  • Global
From
Oncology Collaboration and Licensing Deals 2021-2026 - Product Thumbnail Image

Oncology Collaboration and Licensing Deals 2021-2026

  • Report
  • October 2026
  • 1400 Pages
  • Global
From
Oral Solid Dosage Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Finished Dosage Form, Type of Packaging, Scale of Operation, Company Size, Therapeutic Area, and Key Geographical Regions - Product Thumbnail Image

Oral Solid Dosage Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Finished Dosage Form, Type of Packaging, Scale of Operation, Company Size, Therapeutic Area, and Key Geographical Regions

  • Report
  • March 2025
  • 296 Pages
  • Global
From
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets - Product Thumbnail Image

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

  • Report
  • October 2024
  • 157 Pages
  • Global
From
Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 2271 Pages
  • Global
From
Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 574 Pages
  • Global
From
Long-Acting Drug Delivery Technologies and Services Market Industry Trends and Global Forecasts to 2035, by Compatible Dosage Form, Principle, Strategy, Type of Molecule Delivered, Type of Material Used, and Key Geographical Regions - Product Thumbnail Image

Long-Acting Drug Delivery Technologies and Services Market Industry Trends and Global Forecasts to 2035, by Compatible Dosage Form, Principle, Strategy, Type of Molecule Delivered, Type of Material Used, and Key Geographical Regions

  • Report
  • March 2025
  • 291 Pages
  • Global
From
Depression Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Depression Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 843 Pages
  • Global
From
Liposome Development and Liposome Manufacturing Services Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Product Formulation, Scale of Operation, Type of End User, and Key Geographical Regions - Product Thumbnail Image

Liposome Development and Liposome Manufacturing Services Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Product Formulation, Scale of Operation, Type of End User, and Key Geographical Regions

  • Report
  • March 2025
  • 230 Pages
  • Global
From
Drug Overview: Invega Sustenna/Invega Trinza - Product Thumbnail Image

Drug Overview: Invega Sustenna/Invega Trinza

  • Report
  • March 2018
  • 20 Pages
  • Global
From
Bipolar Disorder Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Bipolar Disorder Therapeutics - Global Strategic Business Report

  • Report
  • October 2026
  • 380 Pages
  • Global
From
Treatment Resistant Depression - Global Strategic Business Report - Product Thumbnail Image

Treatment Resistant Depression - Global Strategic Business Report

  • Report
  • October 2026
  • 277 Pages
  • Global
From
Loading Indicator